Literature DB >> 10233885

C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.

W Verbeek1, A F Gombart, A M Chumakov, C Müller, A D Friedman, H P Koeffler.   

Abstract

C/EBPepsilon is essential for granulocytic differentiation. We investigated the role of C/EBPepsilon in the transcriptional activation of various myeloid-specific genes. We found that two C/EBPepsilon isoforms, p32 and p30, possessing transcriptional activation domains were coexpressed in myeloid cells. Interestingly, isoform C/EBPepsilon p30 but not p32 was differentially upregulated in NB-4 promyelocytic leukemia cells treated with retinoids. Both isoforms bound specifically to C/EBP sites in myeloid promoters. The kd for C/EBPepsilon binding to the C/EBP site of the neutrophil elastase promoter was 4.2 nmol/L. In transfection assays using the nonhematopoietic cell line, CV-1, the p32 isoform activated promoters from the myeloid-specific mim-1, neutrophil elastase, and granulocyte colony-stimulating factor (G-CSF) receptor genes by 2.5-, 1.8-, and 1.6-fold, respectively. The p30 isoform lacked significant transcriptional activity, suggesting that other hematopoietic-specific factors were required for its function. Consistent with this prediction, transfections into the hematopoietic cell line Jurkat showed a 9.0- and 2.5-fold activation of the mim-1 promoter by the p32 and p30 isoforms, respectively. The additional 32 NH2-terminal residues made p32 a significantly more potent transcriptional activator than p30. T lymphoblasts (Jurkat cells) and immature myeloid cells (eg, Kcl22 cells) expressed high levels of the c-myb hematopoietic transcription factor. Cotransfection of c-myb with either the p32 or p30 isoform of C/EBPepsilon in CV-1 cells cooperatively transactivated the mim-1 promoter by 20- and 16-fold, respectively, and the neutrophil elastase promoter by 10-and 7-fold, respectively. Pulldown assays showed that each C/EBPepsilon isoform interacted directly with the DNA binding domain of the c-myb protein. Further studies showed that Kcl22 myeloid cells only contained active C/EBPepsilon, but not C/EBPalpha, C/EBPbeta, or C/EBPdelta. A mutation of the C/EBP site in the neutrophil elastase promoter markedly decreased the transactivation of the promoter in Kcl22 myeloblasts. These results demonstrate a role for C/EBPepsilon in regulating myeloid promoters, such as neutrophil elastase, probably through a direct interaction with c-myb.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233885

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Identification of the residues in the Myb domain of maize C1 that specify the interaction with the bHLH cofactor R.

Authors:  E Grotewold; M B Sainz; L Tagliani; J M Hernandez; B Bowen; V L Chandler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway.

Authors:  Alexey M Chumakov; Agnes Silla; Elizabeth A Williamson; H Phillip Koeffler
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

Review 3.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

4.  Genetic interaction between Kit and Scl.

Authors:  Julie Lacombe; Gorazd Krosl; Mathieu Tremblay; Bastien Gerby; Richard Martin; Peter D Aplan; Sebastien Lemieux; Trang Hoang
Journal:  Blood       Date:  2013-07-08       Impact factor: 22.113

5.  CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase.

Authors:  Elizabeth A Williamson; Ian K Williamson; Alexey M Chumakov; Alan D Friedman; H Phillip Koeffler
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

6.  Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.

Authors:  K R Calvo; D B Sykes; M Pasillas; M P Kamps
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.

Authors:  C Nicot; R Mahieux; C Pise-Masison; J Brady; A Gessain; S Yamaoka; G Franchini
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  Expression of bactericidal/permeability-increasing protein requires C/EBP epsilon.

Authors:  Miyuki Tanaka; Adrian F Gombart; H Phillip Koeffler; Masaaki Shiohara
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

9.  Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells.

Authors:  C Gaillard; E Le Rouzic; C Créminon; B Perbal
Journal:  Mol Pathol       Date:  2002-10

10.  Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation.

Authors:  Richa Bedi; Jian Du; Arun K Sharma; Ignatius Gomes; Steven J Ackerman
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.